Axim Planning & Wealth Takes Position in Cellebrite DI Ltd. $CLBT

Axim Planning & Wealth acquired a new stake in Cellebrite DI Ltd. (NASDAQ:CLBT) in the second quarter, HoldingsChannel reports. The institutional investor acquired 10,800 shares of the company’s stock, valued at approximately $173,000.

Other hedge funds also recently made changes to their positions in the company. Assetmark Inc. bought a new stake in Cellebrite DI during the 1st quarter worth about $33,000. Signaturefd LLC grew its holdings in Cellebrite DI by 68.3% during the 2nd quarter. Signaturefd LLC now owns 2,019 shares of the company’s stock worth $32,000 after acquiring an additional 819 shares during the last quarter. Virtus Advisers LLC bought a new stake in Cellebrite DI during the 1st quarter worth about $63,000. Hennessy Advisors Inc. bought a new position in shares of Cellebrite DI in the 2nd quarter valued at about $83,000. Finally, Advisors Asset Management Inc. boosted its stake in shares of Cellebrite DI by 24.7% in the 1st quarter. Advisors Asset Management Inc. now owns 6,133 shares of the company’s stock valued at $119,000 after purchasing an additional 1,214 shares during the last quarter. Institutional investors and hedge funds own 45.88% of the company’s stock.

Cellebrite DI Price Performance

Cellebrite DI stock opened at $15.90 on Wednesday. The company’s 50 day simple moving average is $17.82 and its 200 day simple moving average is $16.82. Cellebrite DI Ltd. has a fifty-two week low of $13.10 and a fifty-two week high of $26.30. The firm has a market capitalization of $3.81 billion, a price-to-earnings ratio of -20.92, a PEG ratio of 3.16 and a beta of 1.28.

Cellebrite DI (NASDAQ:CLBT) last released its quarterly earnings data on Thursday, August 14th. The company reported $0.12 earnings per share for the quarter, topping the consensus estimate of $0.11 by $0.01. The business had revenue of $113.28 million for the quarter, compared to analyst estimates of $112.33 million. Cellebrite DI had a negative net margin of 34.56% and a positive return on equity of 23.92%. Cellebrite DI’s quarterly revenue was up 18.4% compared to the same quarter last year. During the same quarter last year, the firm earned $0.10 EPS. Cellebrite DI has set its Q3 2025 guidance at EPS. FY 2025 guidance at EPS. As a group, analysts predict that Cellebrite DI Ltd. will post 0.3 EPS for the current fiscal year.

Analyst Ratings Changes

Several research analysts have recently issued reports on CLBT shares. Lake Street Capital reduced their target price on shares of Cellebrite DI from $24.00 to $22.00 and set a “buy” rating on the stock in a research note on Friday, August 15th. JPMorgan Chase & Co. raised their target price on shares of Cellebrite DI from $20.00 to $23.00 and gave the company an “overweight” rating in a research note on Wednesday, September 24th. Wall Street Zen raised shares of Cellebrite DI from a “hold” rating to a “buy” rating in a research note on Friday, September 26th. Needham & Company LLC reduced their target price on shares of Cellebrite DI from $24.00 to $18.00 and set a “buy” rating on the stock in a research note on Thursday, August 14th. Finally, Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Cellebrite DI in a research note on Wednesday, October 8th. Four analysts have rated the stock with a Buy rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, Cellebrite DI currently has a consensus rating of “Moderate Buy” and a consensus price target of $21.75.

Cellebrite DI Profile

Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, cryptocurrency, and intellectual property theft.